Press releases | WebDisclosure

Basculer en Français

9943	Companies
201109	Keywords
131825	Articles
106843	Press releases

Home
Press releases

PRESS RELEASE

published on 04/23/2025 at 20:47, 10 months 7 days ago

H2APEX receives shareholder loan and plans capital increase for further expansion of its hydrogen production capacities
H2APEX secures EUR 35M for hydrogen production expansion; plans EUR 30M capital increase, signs loan agreement and comfort letter, targets industrial-scale growth in Germany

Capital Increase H2APEX Hydrogen Production Shareholder Loan Industrial-scale Growth
PRESS RELEASE

published on 04/23/2025 at 20:42, 10 months 7 days ago

EQS-Adhoc: H2APEX Group SCA: Issuance of a Convertible Loan and a Comfort Letter; Planning of a Capital Increase
H2APEX Group SCA plans EUR 30 million capital increase through convertible loan issuance and comfort letter, aiming for business model development

Capital Increase H2APEX Group SCA Business Model Convertible Loan Comfort Letter
PRESS RELEASE

published on 04/23/2025 at 20:30, 10 months 7 days ago

Inside Information / Other news releases
GenSight Biologics to hold Annual General Meeting on May 13, 2025 at 2:00 pm CEST in Paris, France. Procedures for obtaining preparatory documents outlined

Annual General Meeting Preparatory Documents GenSight Biologics Gene Therapies Retinal Diseases
PRESS RELEASE

published on 04/23/2025 at 20:30, 10 months 7 days ago

Informations privilégiées / Autres communiqués
GenSight Biologics annonce son Assemblée Générale Mixte le 13 mai 2025 à Paris. Documents préparatoires disponibles en ligne

Documents Préparatoires Assemblée Générale Mixte GenSight Biologics Thérapies Géniques Neurodégénératives
PRESS RELEASE

published on 04/23/2025 at 20:03, 10 months 7 days ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Funding Circle Holdings plc repurchases 46,436 ordinary shares on the London Stock Exchange for cancellation at prices between 104.40p and 108.20p

London Stock Exchange Share Repurchase Cancellation Funding Circle Holdings PLC Investec
PRESS RELEASE

published on 04/23/2025 at 19:35, 10 months 7 days ago

Cibox : Résultats Annuels 2024 et Chiffre d'affaires T1 2025
CIBOX publie ses résultats annuels 2024 avec un doublement du chiffre d'affaires, une dynamique positive et une bonne performance commerciale. Prévision de croissance pour 2025

Chiffre D'affaires Croissance Résultats Annuels CIBOX Micro-mobilité
PRESS RELEASE

published on 04/23/2025 at 19:00, 10 months 7 days ago

DÉCALAGE DE LA PUBLICATION DES COMPTES SEMESTRIELS 2024-2025 AU 29 AVRIL 2025
HRS, leader européen des stations de ravitaillement en hydrogène, reporte la publication de ses comptes semestriels 2024-2025 du 24 au 29 avril 2025 après bourse pour finaliser les travaux en normes IFRS

IFRS Hydrogène HRS Stations De Ravitaillement Comptes Semestriels
PRESS RELEASE

published on 04/23/2025 at 19:00, 10 months 7 days ago

POSTPONEMENT OF THE PUBLICATION OF THE 2024-2025 HALF-YEAR FINANCIAL STATEMENTS TO APRIL 29, 2025
HRS, French hydrogen refueling solutions leader, delays the financial statement publication to ensure accuracy. Offers modular stations & comprehensive services

Innovation Financial Statements HRS Hydrogen Refueling Modular Stations
PRESS RELEASE

published on 04/23/2025 at 18:59, 10 months 7 days ago

AB Science announces that EMA granted orphan drug status to AB8939 for the treatment of acute myeloid leukemia
AB Science's AB8939 granted orphan drug designation by EMA in EU for treating acute myeloid leukemia, showing significant benefit over current therapies. Preclinical data reveals efficacy and safety

Orphan Drug Designation AB Science EMA AB8939 Acute Myeloid Leukemia
PRESS RELEASE

published on 04/23/2025 at 18:59, 10 months 7 days ago

La molécule AB8939 obtient la désignation de médicament orphelin auprès de l'EMA dans le traitement de la leucémie myéloïde aigue
La molécule AB8939 obtient la désignation de médicament orphelin dans l'Union Européenne pour le traitement de la leucémie myéloïde aigüe. AB Science fait un pas important dans le domaine de la recherche médicale

Traitement AB Science Médicament Orphelin AB8939 Leucémie Myéloïde Aiguë

Accesswire

Published on 03/01/2026 at 15:00, 3 minutes ago

Sterling Metals Discovers Cu-Mo Porphyry Stock 1.5km from MEPS Discovery Zone Confirming Scale of Porphyry Copper System
Published on 02/28/2026 at 10:00, 1 day 5 hours ago

Storm Exploration Issues Shares to Eabametoong First Nation
Published on 02/28/2026 at 03:00, 1 day 12 hours ago

Dynamite Blockchain Announces Change in Auditor
Published on 02/28/2026 at 02:00, 1 day 13 hours ago

Empress Reports 2025 Year End Financial Results
Published on 02/28/2026 at 00:10, 1 day 14 hours ago

Algo Grande Copper Closes Oversubscribed $6.52 Million Financing and Strengthens Board at AGM

View all ACCESSWIRE

EQS Group

Published on 03/01/2026 at 11:05, 3 hours 58 minutes ago

Acwa Board of Directors names Dr. Samir J. Serhan Chief Executive Officer
Published on 03/01/2026 at 10:30, 4 hours 33 minutes ago

Huawei Launches Comprehensive U6GHz Portfolio to Unlock 5G-A Potential and Pave the Way for 6G
Published on 02/28/2026 at 21:50, 17 hours 13 minutes ago

CARLSBERG MAKES EVERY FAN FEEL PART OF MATCHDAY WITH BSL RENDITION OF "YOU'LL NEVER WALK ALONE"
Published on 02/28/2026 at 21:20, 17 hours 43 minutes ago

Huawei's SuperPoD Portfolio Creates New Option for Global Computing at MWC Barcelona 2026
Published on 02/28/2026 at 21:00, 18 hours 3 minutes ago

CARLSBERG MAKES EVERY FAN FEEL PART OF MATCHDAY WITH BRITISH SIGN LANGUAGE RENDITION OF 'YOU'LL NEVER WALK ALONE'

Les Echos

Published on 02/27/2026 at 23:12, 1 day 15 hours ago

ENGIE - Résultats ABB
Published on 02/27/2026 at 23:00, 1 day 16 hours ago

Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
Published on 02/27/2026 at 23:00, 1 day 16 hours ago

Biophytis porte à 2 m€ le plafond de sa ligne obligataire avec Hexagon Capital Fund
Published on 02/27/2026 at 18:02, 1 day 21 hours ago

AXA: Execution of a share repurchase agreement in relation to AXAs share buy-back program of up to Euro 1.25 billion
Published on 02/27/2026 at 18:02, 1 day 21 hours ago

AXA: Conclusion d’une convention de rachat d’actions dans le cadre du programme de rachat d’actions d’AXA

View all LES ECHOS COMFI WIRE